| abstract |
The present invention belongs to the field of drug chemistry, and more specifically, to a URAT1 inhibitor compound having a uric acid excretion promoting action which is a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof, and according to a test, The compounds of the present invention have a sufficiently good inhibitory effect on the urate transport of hURAT1 in HEK293-transfected cell lines, and the compounds have good promise in the treatment of hyperuricemia and gout disease. [Chemical 1] |